19, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk’s OZEMPIC Approval Heat Up the Chronic Kidney Disease Therapeutic ... Stimulating Agents (ESAs), Angiotensin-Converting Enzyme Inhibitors (ACE-Is ...

Meet mild, reversible acute kidney injury (AKI) -- a sudden loss of kidney function that can go away within 24 hours or, if unchecked, can lead to chronic kidney failure, dialysis or transplant! It ...

Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) gapped down prior to trading on Friday after the company announced weaker than expected quarterly earnings. The stock had ...

S L E is a chronic multisystem autoimmune disease in which cardiovascular disease is a leading cause of mortality, with a ...

Instead, a different type of medication called thiazide diuretics may work better and cause fewer side effects. Doctors have ...

Company to submit sNDA around the end of 1Q 2025 seeking traditional approval of FILSPARI® (sparsentan) for FSGSNet product sales of FILSPARI ...

Louisiana State Employees Retirement System boosted its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.4% during the 4th quarter, according to the company ...